¸ÞÀΠ ·Î±×ÀΠ ȸ¿ø°¡ÀÔ  °í°´¼¾ÅÍ   
°³¸·33Àϰ
  ÀÚÀ¯°Ô½ÃÆÇ  
  Áøµµ°³ÀÚ·á½Ç  
  »ð»ì°³ÀÚ·á½Ç  
  ³Ë»ç³ÉÀÚ·á½Ç  
  ÅäÁ¾°³¿ì¼ö°ß  
  ÅäÁ¾°³Ä÷³  
  ³Ë»ç³ÉÄ÷³  
  ȸ¿øº¸À¯°ß  
Home > Çѱ¹ÀÇÅäÁ¾°³ > ÀÚÀ¯°Ô½ÃÆÇ  
 
ÀÛ¼ºÀÏ : 05-10-14 12:38
½ÉÀå»ç»óÃæ¿¡ ´ëÇÑ ÀÚ·á 2 (ÀÚ·áÃâó http://blog.naver.com/bluecame)
 ±Û¾´ÀÌ : ÓàøÚ
Á¶È¸ : 55   Ãßõ : 1   ºñÃßõ : 0  
ÀÌ ¹®¼­ÀÇ ¸ñÀû
Àú´Â Àü¹®°¡(¼öÀÇ»ç µî)°¡ ¾Æ´Ï¸ç ´ÜÁö °³¸¦ Ű¿ì°í ÀÖÀ¸¸ç °³µéÀÇ °Ç°­¹®Á¦¿¡ °ü½ÉÀÌ ÀÖ´Â ÇÑ »ç¶÷ÀÏ»ÓÀÔ´Ï´Ù. À̸¦ °¡Áö°í ¹®Á¦¸¦ »ïÀ¸½Ã´ÂºÐµéÀÌ °è½Åµ¥, ¼­µÎ¿¡ ¸íÈ®È÷ ¹àÈ÷´Â ¹ÙÀÔ´Ï´Ù. Àú´Â Àü¹®°¡°¡ ¾Æ´Ï¸ç ±×·¸±â ¶§¹®¿¡ Âü°í°¡´ÉÇÑ °¡Àå Àü¹®ÀûÀÌ°í ¸íÈ®ÇÑ ÀڷḦ Âü°íÇßÀ¸¸ç, Á¦ °³ÀÎÀûÀÎ »ý°¢À̳ª ÁÖÀåÀº ¹èÁ¦ÇÒ°ÍÀÔ´Ï´Ù.

½ÉÀå»ç»óÃæÀÌ ¹«¼­¿îº´À̶ó´Â °ÍÀº ´Ùµé Àß ¾Ë°í °è½Ç°ÍÀÔ´Ï´Ù. ÇÏÁö¸¸ ¿Ö ¹«¼­¿îÁö, ¾ó¸¶³ª ¹«¼­¿îº´ÀÎÁö, °É¸®¸é ¾î¶»°Ô µÇ´ÂÁö¿¡ ´ëÇØ¼­ ¾Ë·ÁÁÖ´Â »ç¶÷Àº ¾Æ¹«µµ ¾ø½À´Ï´Ù. ¼ÒÀ§ °³ÆÇ À̶ó´Â °÷Àº ·ç¸Ó°¡ ¸¹Àº °÷ÀÔ´Ï´Ù. ÀÌ·± ·ç¸Óº¸´Ù´Â »ç½Ç¿¡ ±Ù°ÅÇÑ ½ÉÀå»ç»óÃæ ¹× ½ÉÀå»ç»óÃæ ¿¹¹æ¿¡ ´ëÇÏ¿© ¸»Çغ¸°íÀÚ ÇÕ´Ï´Ù.

Á¶±Ý¾¿ »ìÀ» ºÙ¿©¼­ ½ÉÀå»ç»óÃæ¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ¾È³»¼­ÀûÀÌ µÉ¶§±îÁö ¾÷µ¥ÀÌÆ® ÇØº¸°Ú½À´Ï´Ù.
ÀÌ ³»¿ëÀº ÀúÀÇ ³×À̹ö ºí·Î±×¿¡ »õ·Î¿î Á¤º¸°¡ Ãß°¡µÉ¶§¸¶´Ù ¾÷µ¥ÀÌÆ® µË´Ï´Ù.
http://blog.naver.com/bluecame

ÀÌ ¹®¼­ÀÇ ÀúÀÛ±ÇÀº Àú¿¡°Ô ÀÖÀ¸¸ç, ´Ù¸¥°÷¿¡ ¿Å±â½Ç¶§´Â ²À Ãâó¸¦ ¹àÇôÁּžßÇÕ´Ï´Ù. ¾È±×·³ ÀÀ¡µé¾î°©´Ï´Ù. ^^ ´ç¿¬ÇÑ À̾߱âÀ̰ÚÁö¸¸, »ó¾÷ÀûÀÎ ¿ëµµ·ÎÀÇ »ç¿ëÀº ±ÝÇÕ´Ï´Ù.
  
º»¹®ÀÇ ³»¿ëÁß¿¡ »ç½Ç°ú ´Ù¸£°Å³ª °´°ü¼ºÀÌ °á¿©µÈ ºÎºÐÀÌ ÀÖÀ¸¸é ¾Æ·¡ ¸ÞÀÏÁÖ¼Ò·Î Á¦º¸ ºÎʵ右´Ï´Ù.
bluecame@gmail.com

°³ÀÎÀûÀ¸·Î ½ÉÀå»ç»óÃæ °¨¿°¿¡ °ü·ÃµÈ Åë°èÁ¶»ç¸¦ Çϰí ÀÖ½À´Ï´Ù. Ȥ½Ã Á÷Á¢ Ű¿ì½Ã°Å³ª ÁÖº¯¿¡¼­ Ű¿ì´Â ºÐµéÀÇ °³µéÁß¿¡¼­ ½ÉÀå»ç»óÃæ¿¡ °É¸° ¾ÖµéÀÌ ÀÖÀ¸¸é, Á¦ ºí·Î±×ÀÇ ¾Æ·¡±ÛÀ» ÂüÁ¶Çϼż­ Á¦º¸ÇØÁֽøé Ȱ¿ëÇÏ¿© ½ÉÀå»ç»óÃæÀÇ °¨¿°À» °úÇÐÀûÀ¸·Î ¿¹¹æÇϰí, ¶Ç ½ÉÀå»ç»óÃæ¾àÀÇ ¹«ºÐº°ÇÑ »ç¿ëÀ» ÀÚÁ¦Çϴµ¥¿¡ Áß¿äÇÑ ÀÚ·á·Î »ç¿ëÇϰڽÀ´Ï´Ù. ¸¹Àº ¿©·¯ºÐµéÀÇ µµ¿ò ºÎʵ右´Ï´Ù. ÂÊÁö³ª À§ÀÇ ¸ÞÀÏÁÖ¼Ò·Î ¿¬¶ôºÎʵ右´Ï´Ù.

http://blog.naver.com/bluecame/80013968858


v1.5 ¾÷µ¥ÀÌÆ® ³»¿ª
- ½ÉÀå»ç»óÃæ °¨¿°ÀÇ Ä¡·á

  ½ÉÀå»ç»óÃæÀÇ °¨¿°°æ·Î

1. ½ÉÀå»ç»óÃæ¿¡°Ô¼­ °¨¿°µÈ °³ÀÇ Ç÷¾×À» ¸ð±â°¡ »¡¸é ÈíÇ÷ÇÒ¶§¿¡ ¸¶ÀÌÅ©·ÎÇÊ¶ó¸®¾Æ (»ç»óÃæÀÇ ¾ËÀ̶ó°í °¡Á¤ ÇսôÙ.)°¡ °°ÀÌ ¸ð±âÀÇ ¸ö¼ÓÀ¸·Î µé¾î°¡°Ô µË´Ï´Ù.

2. ¸ð±âÀÇ ¸ö¼Ó¿¡¼­ 3¹øÀÇ º¯Å°úÁ¤À» °ÅÃļ­ L3 »óÅÂÀÇ À¯ÃæÀÌ µÇ¸é À̶§ ºñ·Î¼­ ´Ù¸¥ °³¸¦ °¨¿°ÇÒ¼ö ÀÖ´Â »óŰ¡ µË´Ï´Ù. L3 À¯ÃæÀº ¸ð±âÀÇ Å¸¾×À» ÀúÀåÇϴ ħ»ùÀ¸·Î ÀÚ¿¬È÷ À̵¿ÇÕ´Ï´Ù. ¸¶ÀÌÅ©·Î Çʶ󸮾ư¡ L3 ´Ü°èÀÇ À¯ÃæÀ¸·Î ¼ºÀåÇϱâ±îÁö´Â ¾à 14ÀÏÀÇ ½Ã°£ÀÌ ÇÊ¿äÇÕ´Ï´Ù. ÀÌ 14Àϵ¿¾È¿¡´Â Ç×»ó ¼·¾¾ 14µµ ÀÌ»ó À¯ÁöµÇ¾î¾ßÇÕ´Ï´Ù. ±×·¸Áö¾ÊÀ¸¸é  L3 À¯ÃæÀ¸·Î º¯Å¸¦ ÇÏÁö ¸øÇÏ°í µµÅµǾî¹ö¸³´Ï´Ù.

3. ¸ð±âÀÇ Ä§»ù¿¡ L3 À¯ÃæÀÌ À§Ä¡Çϸé ÀÌ ¸ð±â´Â ÀÏ´Ü ½ÉÀå»ç»óÃæÀ» °¨¿°ÇÒ¼ö ÀÖ´Â »óŰ¡ µË´Ï´Ù. ÀÚ ÀÌÁ¦ ÀÌ ¸ð±â°¡ ´ç½ÅÀÇ °³¸¦ ÈíÇ÷Çß´Ù°í °¡Á¤Çغ¾½Ã´Ù. ±×·¸´Ù¸é ¹Ù·Î »ç»óÃæ¿¡ °¨¿°µÇ´Â°¡ ÇÏ¸é ±×·¸Áöµµ ¾Ê½À´Ï´Ù. ¸ð±â´Â ÈíÇ÷À» ÇÑ ´ÙÀ½¿¡ ÈíÇ÷ÇÑ ÁÖº¯¿¡ ÀÚ½ÅÀÇ Å¸¾×À» È긳´Ï´Ù. ÀÌ Å¸¾×¿¡´Â ¸¶Ãë ¼ººÐÀÌ ÀÖ½À´Ï´Ù. »ç¶÷ÀÌ ¸ð±â¿¡°Ô ¹°·Áµµ Àß ¸ð¸£´Â ÀÌÀ¯´Â ÀÌ Å¸¾×¶§¹®ÀÔ´Ï´Ù. ±×¸®°í ÀÌ Å¸¾× ¶§¹®¿¡ ¸ð±â°¡ ¹°¸° ÀÚ¸®¿¡ °¡·Á¿òÁõÀ» ´À³¢°Ô µË´Ï´Ù.

¸ð±â°¡ ´ç½ÅÀÇ °³¸¦ ÈíÇ÷Çϰí ÈíÇ÷ÇÑ ±¸¸Û ÁÖÀ§¿¡ ÀÚ½ÅÀÇ Å¸¾×À» »Ñ·Á³õ½À´Ï´Ù. ÀÌ Å¸¾×¿¡´Â L3 ´Ü°èÀÇ ½ÉÀå»ç»óÃæ À¯ÃæÀÌ Àִ°ÍÀÌÁö¿ä. ÀÌ Å¸¾×¿¡ µé¾îÀÖ´ø ½ÉÀå»ç»óÃæÀÇ L3 À¯ÃæÀº ¸ð±â°¡ ÈíÇ÷Çϱâ À§ÇØ ¶Õ¾î³õÀº ±¸¸ÛÀ» Çì¾öÃļ­ °³ÀÇ ¸ö¼ÓÀ¸·Î ħÅõÇÏ°Ô µË´Ï´Ù.

ÀÚ À̶§¿¡ Áß¿äÇѰÍÀÌ¶Ç ÀÏÁ¤Á¤µµÀÇ ½Àµµ°¡ À¯ÁöµÇÁö ¾ÊÀ¸¸é ¸ð±âÀÇ Å¸¾×Àº ³Ê¹« »¡¸® Áõ¹ßÇØ¹ö·Á¼­, Ÿ¾×¾È¿¡ À§Ä¡Çß´ø L3 À¯Ãæ ¿ª½Ã °³ÀÇ ¸ö¾ÈÀ¸·Î ħÅõÇÒ¼ö°¡ ¾ø½À´Ï´Ù.

4. °³ÀÇ ¸ö¼Ó¿¡ ħÅõÇÑ L3 À¯ÃæÀº ´ÙÀ½´Ü°è·Î º¯ÅÂÇϱâ Àü±îÁö °³ÀÇ ÇÇÇÏÁö¹æºÎºÐ¿¡¼­ ±â»ýÇÕ´Ï´Ù. ¾à 2ÁÖÀÇ ½Ã°£ÀÌ °É·Á¼­ L4 À¯ÃæÀ¸·Î ÁøÈ­ÇÕ´Ï´Ù. ÀÚ ¿©±â¼­ ´Ù½Ã L5 ´Ü°èÀÇ À¯ÃæÀ¸·Î ¼ºÀåÇÏ´Â µ¿¾È¿¡´Â °³ÀÇ ÇÇÇÏÁö¹æ¿¡¼­ ¸Ó¹«¸¨´Ï´Ù. 2-3°³¿ùÁ¤µµÀÇ ½Ã°£ÀÌ °É·Á L5 ´Ü°èÀÇ À¯ÃæÀ¸·Î ¼ºÀåÇϸé, ÇÇÇÏÁö¹æÀ» ¶°³ª¼­ Ç÷°üÀ¸·Î À̻縦 ÇÕ´Ï´Ù. Ç÷°üÀ» ¶°µ¹´Ù°¡ ÀÌ À¯ÃæµéÀº Æóµ¿¸·°ú ½ÉÀåÁ¶Á÷ (ÁÖ·Î ¿ì½É¹æ) ¿¡ ±â»ýÇÕ´Ï´Ù.

5. ¸¶Áö¸· º¯Å¸¦ °ÅÃÄ L6 »óŰ¡ µÇ¸é À̸¦ ¼ºÃæ À̶ó°í ºÎ¸¨´Ï´Ù. ÀÌ ¼ºÃæÀº °³ÀÇ ¸ö¿¡ ħÅõÇÑÁö 5-7°³¿ùÁ¤µµ ÈÄ¿¡ ¦Áþ±â¸¦ Çϸç, ÀÌ Â¦Áþ±â¸¦ ÇÑ ÈÄ¿¡ ¸¶ÀÌÅ©·ÎÇʶ󸮾ư¡ ´Ù½Ã »ý¼ºµË´Ï´Ù.

6. ´Ù¸¥ °¨¿°µÈ ¸ð±âÀÇ L3 À¯ÃæÀÌ ¸ö¾È¿¡ µé¾î¿Í ´Ù½Ã Àç°¨¿°µÇÁö ¾Ê´Â´Ù¸é, ÀÌ ¼ºÃæµéÀº ÀÚ½ÅÀÇ ¼ö¸íÀÎ 2³âÀÇ ¼ö¸íÀ» ´ÙÇϰí Á×¾î¹ö¸³´Ï´Ù. ¸¶ÀÌÅ©·Î ÇÊ¶ó¸®¾Æ ¿ª½Ã ¸ð±â¿¡°Ô ÈíÇ÷µÇÁö ¾Ê´Â´Ù¸é ÀÚ½ÅÀÇ ¼ö¸íÀ» ´ÙÇϰí Á×¾î¹ö¸³´Ï´Ù. ½ÉÀå»ç»óÃæÀÌ ¼ºÃæÀ¸·Î ÀÚ¶ó±â À§Çؼ­´Â ¸ð±â ¶ó´Â ¼÷ÁÖÀÇ Áß°£´Ü°è¸¦ ²À ÇÊ¿ä·Î ÇÕ´Ï´Ù.

  °¨¿°¼öÁØ¿¡ µû¸¥ ÀÓ»óÁõ»ó

°³ÀÇ ½ÉÀå»ç»óÃæ °¨¿°¿¡ µû¸¥ ÀÓ»óÁõ»ó
Ãʱ⠠      Æ¯º°ÇÑ Áõ»óÀÌ ¾øÀ½
ÃÊ-Á߱⠠      ±âħ
Á߱⠰¨¿°        ±âħ, ¿îµ¿±âÇÇÁõ, Æó¿¡¼­ ºñÁ¤»óÀûÀÎ ¼Ò¸® ¹ß»ý (È£Èí½Ã)
ÁßÁõµµ °¨¿°        ±âħ, ¿îµ¿±âÇÇÁõ, È£Èí°ï¶õ, Æó¿¡¼­ ºñÁ¤»óÀûÀÎ ¼Ò¸® ¹ß»ý, °£ºñ´ëÁõ, Á¹µµ (³úÇ÷°ü¿¡¼­ Ç÷°üÈ帧ÀÌ ¾ÈÁÁ¾ÆÁ®¼­ ¹ß»ý) º¹¼öÁõ, ºñÁ¤»óÀûÀÎ ½ÉÀå ¹Úµ¿, »ç¸Á

Âü°íÀÚ·á: American Heartworm Society ÀÇ Canine Heartworm Disease

  °¨¿°ÀÇ °Ë»ç ¹× Áø´Ü

±¹³» ÀÏ¹Ý µ¿¹°º´¿ø¿¡¼­ ÇÏ´Â ½ÉÀå»ç»óÃæ °Ë»ç´Â ŰƮ¸¦ ÀÌ¿ëÇÑ Ç׿ø°Ë»ç¹ý°ú äÃëÇÑ Ç÷¾×À¸·Î Çö¹Ì°æ »ùÇÃÀ» ¸¸µé¾î À°¾ÈÀ¸·Î ¸¶ÀÌÅ©·ÎÇʶ󸮾ÆÀÇ À¯¹«¸¦ È®ÀÎÇÏ´Â Direct Smear ¹ýÀÌ ´ëºÎºÐ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ÀÌ µÎ°¡Áö °Ë»ç¸¦ Çϴµ¥ °¢ º´¿ø¸¶´Ù Â÷À̰¡ ÀÖÀ¸³ª, °³ÀÎÀûÀ¸·Î °Ë»çÇÏ´Â º´¿ø(¼­¿ï°­³²¿¡ À§Ä¡)ÀÇ °¡°ÝÀº 2¸¸ 5õ¿øÀ̸ç, ³ªÀÇ ¹Ý·Á°ßÀº ½Ãº£¸®¾ÈÇ㽺Ű (¾Ï/22kg Á¤µµ) ÀÔ´Ï´Ù. Ç׿ø°Ë»çŰƮ´Â µ¿¹°¾àǰÁ¡¿¡¼­ ¿­°³¿¡ 10¸¸¿øÁ¤µµ Çϴ°ÍÀ¸·Î ¾Ë°í ÀÖ½À´Ï´Ù. (Çϳª´ç ¸¸¿ø²Ã)

1.  Ç÷û ¹ÝÀÀ Å×½ºÆ®

1) Ç׿ø°Ë»ç¹ý
°Ë»çÀÇ °£ÆíÇÔ°ú ³ôÀº Á¤È®¼ºÀ¸·Î ÇöÀç ±¹³»¿¡¼­ Á¦ÀÏ ¸¹ÀÌ ¾Ö¿ëµÇ´Â °Ë»ç¹ýÀÌ´Ù. °¨¿°µÈ °³ÀÇ ¸ö¿¡ Á¸ÀçÇϴ ƯÀÌÇ׿øÀ» °ËÃâÇÏ´Â ¿ø¸®¸¦ ÀÌ¿ëÇÑ´Ù. ÀÚÁÖ ÀÌ¿ëµÇ´Â ŰƮ¸¦ ÀÌ¿ëÇÑ ¹æ¹ý°ú äÃëÇÑ Ç÷¾×À» ½ÇÇè½Ç¿¡ º¸³» Ç׿ø°Ë»ç¸¦ ÅëÇØ¼­ ÇÏ´Â ¹æ¹ýÀÌ ÀÖÀ¸³ª, ±¹³»¿¡¼­´Â ŰƮ¸¦ ÀÌ¿ëÇÑ ¹æ¹ýÀÌ ³Î¸® ÀÌ¿ëµÇ°í ÀÖ´Ù.      
°³Ã¼¼ö°¡ Çϳª ȤÀº ±× ÀÌ»óÀÇ Àû¾îµµ 7-8 °³¿ù ÀÌ»ó ³ªÀ̰¡µéÀº ¾ÏÄÆ ¼ºÃæÀÌ ÀÖÀ» °æ¿ì ¾ç¼º¹ÝÀÀÀ» ³ªÅ¸³½´Ù. ÇÏÁö¸¸, 5°³¿ùÁ¤µµÀÇ °¨¿°Àº ÆÇº°Çس»Áö ¸øÇÑ´Ù.
ÀÌ °Ë»çÀÇ ¾àÁ¡Àº ¼ºÃæÀÇ °¨¿°Á¤µµ ¹× ½ÉÀå³» ħÀÔ ¿©ºÎ, Æäµ¿¸Æ ¹× ½ÉÀåÀÇ È®Àå¿©ºÎ¸¦ ¾Ë±â Èûµé´Ù.

  2) Ç×ü °Ë»ç¹ý
70³â´ë ¸»¿¡¼­ 80³â´ëÃÊ¿¡ ÀÚÁÖ ÀÌ¿ëµÇ¾îÁ³À¸³ª, °£ÆíÇϰí Á¤È®ÇÑ Ç׿ø°Ë»ç¹ýÀ¸·Î ´ëüµÇ¾ú´Ù.

2. ¸¶ÀÌÅ©·ÎÇÊ¶ó¸®¾Æ °¨º° ¹× ÆÇº°¹ý (ÀÚÃæ°Ë»ç)

¸¶ÀÌÅ©·ÎÇÊ¶ó¸®¾Æ °¨º°¹ýÀ¸·Î ¸¶ÀÌÅ©·ÎÇʶ󸮾ư¡ È®ÀÎÀÌ µÇ¸é 100% ¼ºÃæ¿¡ °¨¿°µÇ¾îÁ® Àִ°ÍÀÌ´Ù. Ç׿ø°Ë»ç¿¡¼­´Â ³ªÅ¸³ªÁö ¾ÊÀ¸³ª, ¸¶ÀÌÅ©·ÎÇʶ󸮾ư¡ °ËÃâµÇ´Â°æ¿ì°¡ ²Ï µÇ´Â°ÍÀ» ±¹³» ¿ªÇÐÁ¶»ç ³í¹®µîÀ» ÅëÇØ È®ÀÎÇÏ¿´´Ù.

1) Direct Smear
Áø´Ü°ßÀÇ ¸ö¿¡¼­ äÃëÇÑ Ç÷¾× Çѵιæ¿ï·Î Çö¹Ì°æ »ùÇÃÀ» ¸¸µé¾î¼­, ¹Ù·Î Çö¹Ì°æÀ» ÅëÇÑ À°¾ÈÀ¸·Î È®ÀÎÇÏ´Â ¹æ¹ýÀÌ´Ù. ±¹³»¿¡¼­ ³Î¸® ¾Ö¿ëµÇ°í ÀÖ´Ù.

2) Kott's Test
ÀÏÁ¤·®ÀÇ Ç÷¾×À» äÃëÇÑÈÄ¿¡ À̸¦ ¿ø½ÉºÐ¸®±â¿¡ ³Ö°í ¸¶ÀÌÅ©·ÎÇʶ󸮾Ƹ¸ ºÐ¸®ÇØ ³½ ´ÙÀ½¿¡ À̸¦ °Ë»çÇÏ´Â ¹æ¹ýÀÌ´Ù.

3. °ËÁø¹ý (Physical Examination)

ÃÊ-Áß±âÀÇ °¨¿°°ßµéÀº °ËÁø½Ã¿¡ ¿Ïº®ÇÏ°Ô Á¤»óÀ¸·Î ³ªÅ¸³¯¼öµµ ÀÖ´Ù. ¾î¶´ø°£¿¡ ÁßÁõµµ °¨¿°Àº ¿ìÃø ½ÉÀå Àå¾Ö¸¦ È®ÀÎÇÒ¼ö ÀÖ´Ù. È£Èí°ï¶õ, ȤÀº µüµü°Å¸®´Â ¼Ò¸®°¡ ûÁø °¡´ÉÇÏ´Ù. °¡Àå ¸ÕÀú ¹ß°ßµÇ´Â ÀÌ»óÁõ»óÀº ¿îµ¿±âÇÇ¿Í ¸¸¼º ±âħÀÌ´Ù. ½É¹Ú±Þ¼ÓÁõ, º¹¼öÁõ, °£ºñ´ëÁõÀº ¿ìÃø½ÉÀå Àå¾Ö¸¦ ³ªÅ¸³»´Â Áõ»óÀÌ´Ù. Æóµ¿¸Æ¿¡¼­ÀÇ ÁßÁõµµ °¨¿°Àº ±âħ°ú ÇÔ²² °´Ç÷À» ÇÒ¼öµµ ÀÖ´Ù. ½Ä¿å°¨Åð, üÁß°¨¼Ò, Á¹µµ(±âÀý), Ȳ´ÞÁõ¼¼ (ÇǺÎ, ÀÕ¸ö) µîÀº ÁßÁõµµ °¨¿°½Ã ³ªÅ¸³ª´Â ÁÖ¿ä Áõ»óÀÌ´Ù. Áõ»óÀº ¼ºÃæÀÌ °¨¿°µÈ À§Ä¡¿¡ µû¶ó °¢°¢ ´Ù¸£°Ô ³ªÅ¸³ªÁö¸¸, ´ëºÎºÐÀÇ °æ¿ì Æó¿Í ½ÉÀå¿¡ °¨¿°µÈ ¼ºÃæÀÌ À§Ä¡ÇÑ´Ù.

4. X-ray ÆÇº°¹ý

³ªµµ ¹«½ÄÇÒ¶§¿¡´Â X-ray ÂïÀ¸¸é, ½ÉÀå»ç»óÃæÀÌ X-ray »ó¿¡ º¸ÀÌ´ÂÁٷθ¸ ¾Ë¾Ò´Ù. (¤Ì.¤Ì) ÇÏ¿©°£ X-ray °¨º°Àº ¿©·¯°¡Áö ³»Àå±â°üÀÇ »óŸ¦ º¸°í ÆÇº°ÇÑ´Ù. °¡Àå ½±°Ô ÆÇº°ÇÒ¼ö ÀÖ´Â °ÍÀº ½ÉÀåÀÇ ¿ì½É¹æÀÌ ºñ´ëÇØÁ®¼­ ÀüüÀûÀÎ ½ÉÀåÀÇ ¸ð½ÀÀÌ Reverse-D (DÀÚ¸¦ °Å²Ù·Î µÚÁý¾î³õÀºµíÇÑ) Çü»óÀ» ¸¸µé¾î³»´Â°ÍÀÌ´Ù. ´õ ÀÚ¼¼È÷ ¾Ë°í½ÍÀ¸¸é. ¾Æ·¡ »çÀÌÆ®¿¡ °¡¼­ ±×¸²±¸°æÇÏ°í ¿À½Ã±â ¹Ù¶õ´Ù.

5. ÃÊÀ½ÆÄ °¨º°¹ý, Ç÷°üÁ¶¿µ¼ú

ÃÊÀ½ÆÄ °¨º°Àº ±× ¼ýÀÚ°¡ 50¸¶¸®ÀÌ»ó µÇ¾îÁ®¾ßÁö °¨º°ÀÌ °¡´ÉÇÏ´Ù°í ÇÑ´Ù. ±¹³»¿¡¼­ Áøµµ°ßÀ» ´ë»óÀ¸·ÎÇÑ ÃÊÀ½ÆÄ Áø´Ü¿¡ °üÇÑ ¿¬±¸¶ó´Â ³í¹®À» ÂüÁ¶Çϱ⠹ٶø´Ï´Ù. Ç÷°üÁ¶¿µ¼úÀº °ÅÀÇ ¾²À̰í ÀÖÁö ¾Ê½À´Ï´Ù.

  ½ÉÀå»ç»óÃæ ¼ºÃæ °¨¿°ÀÇ Ä¡·á

1. ½ÉÀå»ç»óÃæ¼º ÇǺο°

ÇÇÇÏÁö¹æ¿¡ ¸Ó¹°´ø 3±â À¯ÃæÀÌ µÎ¹øÀÇ Å»ÇǸ¦ °ÅÃļ­ Ç÷°üÀ¸·Î À̵¿Çϸ鼭 »ý±â´Â °áÀý

2. Ä¡·á¿¡ µå´Â ºñ¿ë

Àû°Ô´Â 4-50 ¸¸¿ø¿¡¼­ ¸¹°Ô´Â 100¸¸¿ø Á¤µµ±îÁö º´¿ø¸¶´Ù Ʋ¸³´Ï´Ù. ÇöÀç ½ÉÀå»ç»óÃæ Ä¡·á·Î FDA ÀÇ ½ÂÀÎÀ» ¹ÞÀº ¾àÀº Immiticide ´Ü Çϳª»ÓÀÔ´Ï´Ù.
ÀÌ ¾àǰÀÇ °¡°ÝÀÌ ÀÏ¹Ý ÁÖ»çÁ¦¿Í Ʋ¸®°Ô ¸Å¿ì °í°¡¿©¼­ ½ÉÀå»ç»óÃæ ¼ºÃæ°¨¿°ÀÇ Ä¡·á¿¡ µå´Â ºñ¿ëÀÌ ¸Å¿ì ¸¹ÀÌ µì´Ï´Ù.

3. ½ÉÀå»ç»óÃæ °¨¿°ÀÇ ´Ü°è

½ÉÀå»ç»óÃæÀÇ °¨¿°Á¤µµ¸¦ grade 1 - grade 4 ·Î ³ª´©¾î Ä¡·á¹æ¹ýÀ» ´Þ¸®Çϰí ÀÖ½À´Ï´Ù. (Immiticide »ç¿ë ¼³¸í¼­ ÂüÁ¶)

Group I: Lowest Risk. Young healthy dogs with minimal disease evident on radiographs, normal blood work, and no symptoms of illness.


¡¤  ±×·ì1 : ÀûÀº À§Çè, ³ªÀÌ ¾î¸°°³, X-ray »óÀÇ °æµµ °¨¿° È®ÀÎ, Á¤»óÀûÀÎ Ç÷¾×°Ë»ç¼öÄ¡, ¾Æ¹« Áõ»ó ¹ß°ß¾ÈµÊ  

¡¤  Group II: Moderately Affected. Some coughing, moderate radiographic changes but normal bloodwork.

¡¤  ±×·ì2: Áß±Þ °¨¿°. °¡²û ±âħ, X-ray »ó Áß±Þ °¨¿°ÀÇ Áõ»ó º¯È­°¡ È®Àεdzª, Ç÷¾×°Ë»ç ¼öÄ¡´Â Á¤»ó
  
¡¤  Group III: Severely Affected. Dog is suffering from weight loss, cough, difficulty breathing, blatant damage to the vasculature is apparent on radiographs, bloodwork reveals kidney and/or liver damage.

¡¤  ±×·ì3 : ½ÉÇÑ °¨¿°. üÁß°¨¼Ò, ±âħ, È£Èí°ï¶õ, X-ray »óÀÇ Ç÷°ü È®½ÇÇÑ Ç÷°ü ¼Õ»ó È®ÀÎ, ÇÛ¾×°Ë»ç °á°ú´Â ½ÅÀå¼Õ»ó°ú °£¼Õ»ó ±×¸®°í °£¼Õ»ó¸¸ ¹ß°ßµÇ±âµµÇÔ
¡¤  Group IV: Caval Syndrome.  Dog is collapsing in shock with dark brown urine evident. Heartworms visible by ultrasound in the AV valve of the right side of the heart, very abnormal bloodwork.  These dogs, as mentioned previously, are dying and can only be saved by the physical removal of adult heartworms via an incision through the jugular vein. If such a dog can be saved from this crisis, further heartworm infection treatment cannot be contemplated until the dog is stable enough to fit into one of the other categories above.

±×·ì4: Ä«¹ß ½Åµå·Ò. £Àº °¥»ö ¼Òº¯Áõ»ó°ú ÇÔ²² ¼îÅ©·Î ±âÀýÁõ¼¼¸¦ ³ªÅ¸³½´Ù. ÃÊÀ½ÆÄ·Î ¿ìÃø ½ÉÀå ÆÇ¸·¿¡¼­ ½ÉÀå»ç»óÃæÀÌ È®ÀÎ °¡´ÉÇÏ´Ù. ¸Å¿ì ºñÁ¤»óÀûÀÎ Ç÷¾×°Ë»ç ¼öÄ¡. ÀÌ °æ¿ì¿¡´Â ¼ö¼úÀ» ÅëÇÑ °æÁ¤¸ÆÀÇ ½ÉÀå»ç»óÃæ Á¦°Å¿Ü¿¡´Â »ýÁ¸È®·üÀÌ Èñ¹ÚÇÏ´Ù. ÀÌ ±×·¹À̵åÀÇ °³°¡ ´Ù¸¥ ½ÉÀå»ç»óÃæ Ä¡·á¸¦ ¹ÞÀ¸·Á¸é, ±×·ì 1-3 ±îÁöÀÇ »óÅ·Π°Ç°­ÀÌ È¸º¹µÇ¾ß¸¸ Ä¡·á°¡ °¡´ÉÇÏ´Ù.

ÇöÀç ½ÉÀå»ç»óÃæ Ä¡·á¹ýÀº µÎ°¡Áö°¡ ÀÖ½À´Ï´Ù. (American Heartworm Society ¹ßÃé)

1. Immiticide - ºñ¼Ò°è¿­ÀÇ È­ÇÕ¹° ÁÖ»çÁ¦·Î ÀÏ¹Ý µ¿¹° º´¿ø¿¡¼­ Ä¡·áÇÒ¶§ ¾²ÀÌ´Â ¾àÀÔ´Ï´Ù. ÇöÀç±îÁö FDA ¿¡¼­ ½ÂÀÎµÈ ½ÉÀå»ç»óÃæ Ä¡·áÁ¦´Â À̰͹ۿ¡ ¾ø½À´Ï´Ù. ¼öÀǻ簡 ¾Æ´Ñ °³ÀÎÀÌ Ä¡·áÇϱâ´Â Èûµì´Ï´Ù.  24½Ã°£°£°ÝÀ¸·Î 2¹ø ÁÖ»çÇϰųª ÀÏÁÖÀÏ °£°ÝÀ¸·Î 2-3¹ø ÁÖ»çÇϴ°ÍÀÌ ÁÖ·Î ÀÌ¿ëµË´Ï´Ù.
¡¤  
¡¤  ÀÌ Ä¡·áÀÇ ÇÁ·ÎÅäÄÝÀº

   1) Àüó¸® - ¾Æ½ºÇǸ° ÀÏÁÖÀϰ£ ±Þ¿© (¿©±â¿¡ ´ëÇØ ¾ÆÁ÷ ³í¶õÀÌ ¸¹½À´Ï´Ù. Ç÷Àü¿ëÇØ ¸ñÀûÀ¸·Î ÈÄó¸®Áß Prednisolone ´ë½Å Åõ¾àÇϱ⵵ÇÕ´Ï´Ù.  )
   2) Immiticide ÁÖ»çÈÄ 24½Ã°£ °üÂû (Áֱ⿡ µû¶ó)
   3) °üÂû°£ Ç÷Àü (½ÉÀå»ç»óÃæÀÌ ÇѲ¨¹ø¿¡ ±Þ»çÇÏ¿© µ¿¸ÆÀ» ¸·´Â Çö»ó) Áõ»óÀÌ °üÂûµÇ¸é Prednisolone  À» Åõ¾àÇÔ
   4) ÇÑ´Þ°£°ÝÀ¸·Î Ivermectin (ÇÏÆ®°¡µå µî) À» Åõ¾àÇÏ¿© ¸¶ÀÌÅ©·ÎÇÊ¶ó¸®¾Æ ¹× À¯ÃæÁ¦°Å
   5) 4-5 °³¿ùÈÄ¿¡ ½ÉÀå»ç»óÃæ ŰƮ ¹× Ç÷¾× Çö¹Ì°æ °Ë»ç·Î Ä¡·á°¡ Àß µÇ¾ú´ÂÁö È®ÀÎ
       (ÀÌÀ¯´Â Ç׿øÀÌ ¼ºÃæÀÌ Á×´õ¶óµµ 3°³¿ùÀÌ»ó ¸ö¾È¿¡ ³²¾ÆÀֱ⠶§¹®ÀÔ´Ï´Ù.)

2. Ivermectin - 1±â ȤÀº Ãʱâ¹ß°ßÀÇ °æ¿ì (°¨¿°ÈÄ 7°³¿ù³»¿¡) ÇÏÆ®°¡µå °°Àº ¿¹¹æ¾àÀ» ²ÙÁØÈ÷ º¹¿ëÇÔÀ¸·Î½á ½ÉÀå»ç»óÃæ ¼ºÃæ °¨¿°ÀÌ Ä¡·á°¡ °¡´ÉÇÕ´Ï´Ù. ¿ÀÇØ¸¦ ÇÇÇϱâ À§ÇØ AHA ÀÇ ±ÛÀ» ¿ÏÀüÈ÷ ¹ø¿ªÇϵµ·Ï ÇϰڽÀ´Ï´Ù.

¡¤  Continuous monthly administration of prophylactic doses of ivermectin, alone or in combination with pyrantel pamoate, is highly effective against late precardiac larvae and young (<7 month post-infection) adult heartworms. Comparable adulticide capability of the other macrocyclic lactones has not been reported. The adulticide effect of ivermectin generally requires more than a year of continuous monthly administrations and may take more than two years before heartworms are eliminated completely. The older the worms when first exposed to ivermectin, the slower they are to die. In the meantime, the infection persists and continues to cause disease. Therefore, long-term continuous administration of ivermectin generally is not a substitute for conventional arsenical adulticide treatment. If arsenical therapy is declined, a lengthy course of prophylactic doses of ivermectin will gradually reduce the number of adult heartworms, but in chronic mature infections this may not be clinically beneficial. Exercise should be restricted in dogs treated with prophylactic doses of ivermectin as the adulticide.
The results of a recent study in which monthly ivermectin was administered to client-owned heartworm infected dogs for two years indicated that this method of killing adult heartworms should not be used in dogs with signs of heartworm disease or very active dogs, and if used in asymptomatic dogs, the dogs should be examined by a veterinarian at least once every four to six months until all of the worms are dead. As worsening of radiographic signs may be observed, periodic radiographic evaluations may be useful in monitoring the treatment.

Áö¼ÓÀûÀ¸·Î À¯ÃæÁ¦°ÅÇÔ·®ÀÇ À̹ö¸ßƾ°ú ÇǶõÅÚ ÆÄ¸ð¿¹Æ® (ÇÏÆ®°¡µåµî) À» ¸Å´Þ º¹¿ëÇÒ¶§¿¡ Ç÷¾×°¨¿° ÀÌÀüÀÇ ¼ºÃæ¿¡ °¡±î¿î À¯Ãæ°ú ¾î¸° ¼ºÃæµé¿¡°Ô ¸Å¿ì È¿°úÀûÀÌ´Ù. ¼ºÃæÄ¡·áÁ¦ÀÇ Ä¡·áÈ¿°ú¿Í ´Ù¸¥ ½ÉÀå»ç»óÃæ¿¹¹æ¾àÀ» »ç¿ëÇÑ ÀÌ·± Ä¡·á¿¡ ´ëÇÑ È¿°úÀÇ ºñ±³ÀÚ·á´Â Á¸ÀçÇÏÁö ¾Ê´Â´Ù. ÀÌ Ä¡·á¹æ¹ýÀº Àû¾îµµ 1³â ÀÌ»ó Áö¼ÓÀûÀ¸·Î ¿¹¹æ¾àÀ» º¹¿ëÇØ¾ß ÇÏ¸ç ¿ÏÀüÇÑ ¼ºÃæÁ¦°Å¿¡ 2³âÀÌ»ó °É¸±¼öµµ ÀÖ´Ù. ±×·¯¹Ç·Î Àå±â°£ÀÇ À̹ö¸ßƾ º¹¿ëÀÌ ºñ±³Àû °£ÆíÇÑ ºñ¼Ò°è¿­ÀÇ ¼ºÃæÄ¡·á¸¦ ´ëüÇÒ¼ö´Â ¾ø´Ù.  ¸¸¾à ºñ¼Ò Ä¡·á°¡ ºÒ°¡´ÉÇÑ °æ¿ì¿¡´Â Àå±â°£ÀÇ À̹ö¸ßƾ ¿¹¹æ¾àÀ» ¸Å´Þ º¹¿ëÇÏ¹Ç·Î½á ¼ºÃæÀÇ ¼ýÀÚ¸¦ Á¡ÁøÀûÀ¸·Î ÁÙÀϼö ÀÖÀ¸³ª, ±Þ¼º ¼ºÃæ °¨¿°ÀÇ °æ¿ì ÀÌ´Â ÀÓ»óÀûÀ¸·Î µæÀ̵ÇÁö ¾Ê´Â´Ù. ¿¹¹æ¾àÀ» ÀÌ¿ëÇÏ¿© ¼ºÃæÄ¡·á¸¦ ÇÏ´Â °æ¿ì ¿îµ¿Á¦ÇÑÀÌ ²À µ¿¹ÝµÇ¾îÁ®¾ß ÇÑ´Ù.
ÃÖ±Ù ÀϹÝÀο¡ ÀÇÇØ ±æ·¯Áö´Â ½ÉÀå»ç»óÃæ °¨¿°°ßÀ» ´ë»óÀ¸·Î 2³âµ¿¾È  ¸Å´Þ À̹ö¸ßƾÁ¦ ±Þ¿©¸¦ ÅëÇÑ »ç»óÃæ Ä¡·áÀÇ °á°ú¸¦ ÂüÁ¶ÇÒ¶§, À̹ö¸ßƾÁ¦¸¦ ÀÌ¿ëÇØ ¼ºÃæÀ» Á×ÀÌ´Â Ä¡·á´Â ½ÉÀå»ç»óÃæ °¨¿°ÀÇ Áõ»óÀ» º¸À̰ųª ¸Å¿ì ¿îµ¿·®ÀÌ ¸¹°í Ȱ¹ßÇÑ °³µé¿¡°Ô´Â ¼ºÃæÄ¡·á·Î »ç¿ëÇØ¼­´Â ¾ÈµÉµíÇÏ´Ù. ¸¸¾à Áõ»óÀ» º¸ÀÌÁö ¾Ê´Â °¨¿°°ßÀ» ´ë»óÀ¸·Î À̹ö¸ßƾÁ¦ÀÇ Ä¡·á¸¦ ÁøÇàÇÒ °æ¿ì¿¡´Â ¼ºÃæÀÌ ¿ÏÀüÈ÷ Á¦°ÅµÇ±â±îÁö Àû¾îµµ 4ÁÖ ¿¡¼­ 6°³¿ù¿¡ ÇѹøÀº ¼öÀÇ»çÀÇ Áø´ÜÀ» ¹Þ¾Æ¾ßÇÑ´Ù. ¹æ»ç¼±»ó¿¡¼­ Áõ»óÀÇ ¾ÇÈ­°¡ °üÂûµÉ¼öµµ Àֱ⠶§¹®¿¡, Á¤±âÀûÀÎ ¹æ»ç¼± Áø´ÜÀº Ä¡·á¸¦ ¸ð´ÏÅ͸µÇϴµ¥ È¿°úÀûÀϼö ÀÖ´Ù.

3. Black Walnut µîÀ» ÀÌ¿ëÇÑ ´ëü¿ä¹ý

ÇöÀç ¹Ì±¹°ú È£ÁÖ¿¡´Â »ç¶÷ÀÇ ±â»ýÃæ Ä¡·á¿¡ ¹Î°£¿ä¹ýÀ¸·Î ¼öõ³âµ¿¾È »ç¿ëµÇ¾ú´ø Black Walnut °ú Wormwood ¸¦ ÀÌ¿ëÇÑ ÀÚ¿¬¿ä¹ý Ä¡·á ÇÁ·Î±×·¥ÀÌ Á¸ÀçÇÕ´Ï´Ù.
±¸Ãæ±â´ÉÀÌ ÀÖ´Â Çãºê·ù¿Í ½ÉÀå Ç÷°üÀ» º¸Á¶ÇÏ´Â Çãºê¸¦ ÇÔ²² »ç¿ëÇÏ¿© Ç÷¾×³»ÀÇ ±â»ýÃæÀ» ¼­¼­È÷ Á×ÀÌ´Â ¹æ½ÄÀ» »ç¿ëÇÏ´Â°Í °°½À´Ï´Ù.
ÁÖ·Î »ç¿ëµÇ´Â Çãºê´Â ¾Æ·¡¿Í °°½À´Ï´Ù.

±¸ÃæÀÛ¿ë        ½ÉÀå¹× Ç÷°üº¸Á¶        ±âħº¸Á¶
Black Walnut        CoQ10        Yucca
Wormwood        Hwathorn        ¡¡
Artemisia        ¡¡        ¡¡

2002³â Whole Dog Journal¿¡ Bandits ¶ó´Â °³°¡ ¸»±â ÆÇÁ¤À» ¹Þ°í ¿ÏÄ¡µÈ »ç·Ê°¡ ½Ç·ÁÀÖ½À´Ï´Ù. (³»¿ëº¸·¯°¡±â)

  ½ÉÀå»ç»óÃæ ¿¹¹æ¾à

½ÉÀå»ç»óÃæ ¿¹¹æ¾àÀ̶ó´Â °ÍÀº ½ÇÁ¦ ¸Ô¾úÀ»¶§¿¡ ¿¹¹æÈ¿°ú°¡ ÀÖ´Â ¾àÀÌ ¾Æ´Õ´Ï´Ù. ¾ö¹ÐÈ÷ ¸»ÇÏÀÚ¸é L3, L4 ´Ü°èÀÇ À¯ÃæÀ» Á×ÀÌ´Â Ä¡·á¾àÀÔ´Ï´Ù. ½ÇÁ¦ ½ÉÀå»ç»óÃæÀ» ¿¹¹æÇÏ·Á¸é ½ÉÀå»ç»óÃæÀÇ ¼÷ÁÖÀÎ ¸ð±âÀÇ Á¢±ÙÀ» 100% °¡±îÀÌ Â÷´ÜÇÒ¼ö ÀÖ´Â ¹°ÁúÀ̾î¾ß Çϴµ¥ ¾Æ½±°Ôµµ ±×·± ¾àǰÀº ÇöÀç Á¸ÀçÇÏÁö ¾Ê½À´Ï´Ù.

¸¶ÀÌÅ©·ÎÇʶ󸮾ư¡ ¸ð±â¿¡ ÀÇÇØ ÈíÇ÷µÇ¾î L3 À¯ÃæÀ¸·Î ÀÚ¶ó±â±îÂî´Â ¾à 14ÀÏ (2ÁÖ) Á¤µµ°¡ °É¸³´Ï´Ù. ±×·¯³ª ÀÌ·¸°Ô 2Á־ȿ¡ ¼ºÀåÀ» ÇÏ·Á¸é ÃÖÀú ±â¿ÂÀÌ 14µµ ÀÌ»ó ¸ÅÀÏ Áö¼ÓµÇ¾îÁ®¾ß ÇÕ´Ï´Ù. ÇÕ¸®ÀûÀÎ ¿¹¹æ½ÃÀÛÀÏÀ» °áÁ¤ÇϽ÷Á¸é ¸ÅÀϸÅÀÏÀÇ ÃÖÀú±â¿ÂÀ» È®ÀÎÇÏ¿© ÃÖÀú±â¿ÂÀÌ 14µµ ÀÌ»óÀÎ ³¯ÀÌ 2ÁÖ°¡ Áö³­ ½ÃÁ¡À¸·ÎºÎÅÍ 30ÀÏ - 45ÀÏ (ÀÚ½ÅÀÌ ¼±ÅÃÇÑ ¿¹¹æÁÖ±â) ÈÄ¿¡ ÃÖÃÊ·Î ¸ÔÀ̱⠽ÃÀÛÇÏ½Ã¸é µË´Ï´Ù.

¼­¿ïÁö¿ªÀÇ °æ¿ì ¿¬Æò±Õ ÃÖÀú±â¿ÂÀÌ 5¿ùÀÌ 12.6µµ 6¿ùÀÌ 17.8 µµ ÀÔ´Ï´Ù. ±×·¯¹Ç·Î 5¿ù ¸» 6¿ù Ãʸ¦ ¸ÅÀÏ 14µµÀÌ»ó 2ÁÖÀÌ»ó Áö¼ÓµÇ´Â ½ÃÁ¡À¸·Î º»´Ù¸é 30ÀÏ ÀÌÈÄÀÎ 6¿ù¸» ȤÀº 7¿ù ÃÊ ºÎÅÍ ½ÃÀÛÇϴ°ÍÀÌ ÇÕ¸®ÀûÀÎ ¿¹¹æÀ» ÇÒ¼ö ÀÖÀ»°ÍÀÔ´Ï´Ù.

±×´ÙÀ½ 10¿ùÀº ¿¬Æò±ÕÃÖÀú±â¿ÂÀÌ 9.8 µµ À̹ǷΠ10¿ù Áß¼øÀ» ´Ù½Ã 14µµÀÌ»ó 2ÁÖ°£ Áö¼ÓµÇÁö ¾Ê°ÔµÇ´Â ½ÃÁ¡À¸·Î º»´Ù¸é 11¿ù Áß¼ø¿¡ ¸¶Áö¸·À¸·Î ¸Ô´Â°ÍÀÌ ÇÕ¸®ÀûÀ̰ÚÁö¿ä.

  ½ÉÀå»ç»óÃæ ¿¹¹æ¾àÀÇ Á¾·ù

±¹³»¿¡´Â Å©°Ô À̹ö¸ßƾ°è¿­, ¹Ðº£¸¶À̽Š¿Á½É°è¿­, ¼¿¶ó¸ßƾ °è¿­ÀÇ ¾àǰÀÌ ÇöÀç À¯ÅëÁßÀÔ´Ï´Ù. À̹ö¸ßƾ °è¿­ÀÇ ¾àµéÀÌ °¡Àå Á¾·ù°¡¸¹½À´Ï´Ù. ÃÖ±Ù µ¿È£È¸ °ø±¸³ª ÀÎÅÍ³Ý ¾Ö°ß¼îÇθôµî¿¡¼­ ÆÇ¸Å°¡ µÇ´Â ´ÙÀ̷νÅÀ̶ó´Â Á¦Ç°ÀÌ Àִµ¥, ÀÌ´Â »ý¾àÀÌ ÁÖ¼ººÐÀÎ ÀǾàºÎ ¿ÜǰÀ¸·Î ½ÉÀå»ç»óÃæ ¿¹¹æ¿¡ °üÇÑ È¿´É¿¡ °­ÇÑ ÀǽÉÀÌ µå´Â Á¦Ç°À̸ç ÇöÀç ¾à»ç¹ýÀ§¹ÝÀ¸·Î ¼Ò¼ÛÀÌ ÁøÇàÁßÀΰÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ½À´Ï´Ù.

ÇöÇà ¾à»ç¹ý¿¡ µû¸£¸é, ÀǾàºÎ¿ÜǰÀº Á¦Ç°ÀÇ Ä¡·áÈ¿°ú ¹× È¿´ÉÀ» ¸í½ÃÇÏÁö ¸øÇÏ°Ô µÇ¾îÀÖ´Â°Í °°½À´Ï´Ù.

¾î¶² ½ÉÀå»ç»óÃæ¾àÀ» °í¸¦°ÍÀΰ¡? ¶ó´Â °ÍÀº öÀúÇÑ °ßÁÖÀÇ ¼±ÅÃÀÔ´Ï´Ù. ²À ¸Ô¿©¾ß ÇÑ´Ù¸é °¡±ÞÀû ½Ñ Á¦Ç°À» °í¸£´Â°ÍÀÌ ÁÁ½À´Ï´Ù. ÇÏÆ®°¡µå¿Í ÇÏÆ®°ñµå¸¦ Á¦¿ÜÇÑ ´ëºÎºÐÀÇ Á¦Ç°Àº ±âŸ ³»ºÎ±â»ýÃæ ±¸ÃæÈ¿°ú±îÁö ¼³Á¤µÇ¾î ÀÖÀ¸¹Ç·Î, ½ÉÀå»ç»óÃæ¾àÀ» ¸ÔÀ̸鼭 ¸Å´Þ ³»ºÎ±â»ýÃæ ±¸Ãæ¾àÀ» Åõ¿©Çϴ°ÍÀº °­ÁãµéÀÇ °£À» Ȥ»ç½ÃÄÑ ¼ö¸íÀ» ´ÜÃà½ÃŰ´Â Áö¸§±æÀÔ´Ï´Ù. Àúµµ ¹«½ÄÇÑÁË·Î ÀÛ³â±îÁö´Â ½ÉÀå»ç»óÃæ¾àÀ» ¸Å´Þ ¸ÔÀ̸鼭 ±¸Ãæ¾àÀ» ¸Ô¿´¾ú½À´Ï´Ù.

ÀǾàǰ
Á¦Ç°¸í        ¼ººÐ        ÇÔ·®        Á¦Á¶¿ø        ¼öÀÔ¿ø
ÇÏÆ®°¡µå Ãò¾îºí        Ivermectin        68mcg136mcg272mcg         Merial. Co. Ltd        ¿¡½ºÆ¾ÄÚÆÛ·¹À̼Ç
ÇÏÆ®°ñµå        Ivermectin        136mcg/1Á¤        Vetafarm Pty Ltd., Australia        ¢ß »ï¿ì¸Þµð¾È
ÇÏÆ®°¡µå Ç÷¯½º        IvermectinPyrantel Pamoate        6.0mcg/Kg5mg/Kg        Merial. Co. Ltd        ¿¡½ºÆ¾ÄÚÆÛ·¹À̼Ç
ÇÏÆ®Ä°        IvermectinPyrantel Pamoate        6.0mcg/Kg5mg/Kg        ¢ß »ï¿ì¸Þµð¾È        ¡¡
¿£Á©ÇÏÆ®        IvermectinPyrantel Pamoate        6.0mcg/Kg5mg/Kg        ¢ß ´ë¼º¹Ì»ý¹° ¿¬±¸¼Ò        ¡¡
ÇÏÆ®Äɾ      IvermectinPyrantel Pamoate        6.0mcg/Kg5mg/Kg        Cipla, India        anison ¾Ö´Ï½¼ ¢ß
µùÅ©        ?        ?        ?        ?
¹Ðº£¸¶À̽ÅA        Milbermicyn Oxime        0.25mg/Kg        SANKYO (?)        ¢ß Çѵ¿¾àǰ
·¹º¼·ç¼Ç        Selamectin        6ml/Kg        pfizer        Çѱ¹È­ÀÌÀð
¾Öµåº¸Å¶        À̴̹ÙŬ·ÎÇÁ¸®µå Moxidectin        100mg/L25mg/L        ¡¡¹ÙÀÌ¿¤        ¡¡¹ÙÀÌ¿¤ÄÚ¸®¾Æ
ÇÁ·ÎÇÏÆ®6 (ÁÖ»çÁ¦)        Moxidectin        FDA ½ÂÀÎ Ãë¼Ò¿¡ µû¸¥ ÀÚÁø ¸®ÄÝ (2004)
ÀǾàºÎ ¿Üǰ
Á¦Ç°¸í        ¼ººÐ        ÇÔ·®        Á¦Á¶¿ø        ¼öÀÔ¿ø
´ÙÀ̷νŠ       ¸ÞÄ¡¿À´Ñ 0.01% ÀÌ»óÃʸñÃßÃâ¹°(À§·É¼±,»ó¿±,Ȳȭȣ)         ¡¡        ÇÑdzÁ¦¾à (?)        ¡¡È¿´É¿¡ ´ëÇÑ ³í¶õÀÌ

°í¾çÀÌ¿ë Á¦Ç°
Á¦Ç°¸í        ¼ººÐ        ÇÔ·®        Á¦Á¶¿ø        ¼öÀÔ¿ø
ÇÏÆ®°¡µå Ĺ        Ivermectin        165mcg        Merial. Co. Ltd        ¿¡½ºÆ¾ÄÚÆÛ·¹À̼Ç
·¹º¼·ç¼Ç Ĺ        Selamectin        60mg/ml        pfizer        Çѱ¹È­ÀÌÀð


  ½ÉÀå»ç»óÃæÀÇ ¿¹¹æ¾àÀÇ ¾ÈÁ¤ÀûÀÎ Åõ¾àÁÖ±â

¸ðµç Á¦Ç°»ó¿¡ ¸í½ÃµÈ ¿¹¹æÁÖ±â´Â 30ÀÏ ÀÔ´Ï´Ù. ÇÏÁö¸¸, ÀÌ 30 ÀÏ À̶ó´Â ¼ýÀÚ´Â Á¦¾àȸ»ç¿¡¼­ ±ÇÀåÇÏ´Â ¿¹¹æÁÖ±âÀÔ´Ï´Ù. ½ÇÁ¦·Î »ç¿ëÇÏ´Ùº¸¸é, ¸îÀÏ ´Ê°Ô ¸ÔÀϼöµµ ÀÖ°í, ȤÀº ¾î¶²°æ¿ì¿¡´Â ½ÉÀå»ç»óÃæ¾àÀ» ¸Ô¾ú´õ¶óµµ, 100% ½ÉÀå»ç»óÃæ À¯ÃæÀ» Á¦°ÅÇÏÁö ¸øÇÏ´Â °æ¿ìµµ ÀÖÀ»°ÍÀÔ´Ï´Ù. ±×·¡¼­ ¸ðµç ¾àÀÌ ÀýÀýÇÏ°Ô grace period ¸¦ °¨¾ÈÇÏ¿© ¾ÈÀüÇÑ Çѵµ¸¦ ¼³Á¤Çϴµ¥ ÀÌ ¼³Á¤±â°£ÀÌ 30ÀÏÀΰÍÀÔ´Ï´Ù.

½ÉÀå»ç»óÃæ¾àµéÀº Á¾·ùº°·Î ¾à°£¾¿ÀÇ Â÷À̰¡ ÀÖÀ¸³ª
- ¸¶ÀÌÅ©·ÎÇʶ󸮾Æ
- L3 À¯Ãæ
- L4 À¯Ãæ
- ÀϺΠL5
- ÀϺΠL6 (¼ºÃæ)

¿¡ ÀÛ¿ëÇÏ¿© È¿°ú°¡ ÀÖ½À´Ï´Ù. Merck ¼öÀÇ ¸Þ´º¾óÀÇ ³»¿ëÀ» ºô¸®ÀÚ¸é, L3 °¡ ü³»·Î µé¾î¿Í¼­ ½ÇÁ¦ L5 ·Î ¼ºÀåÇϱâ±îÁö °É¸®´Â ½Ã°£Àº 100ÀÏ Á¤µµ¶ó°í ÇÕ´Ï´Ù. ±×·¸´Ù¸é °¢ Á¦Ç°¿¡ µû¶ó 30-90 ÀÏ °£ÀÇ ¿¹¹æÁֱⰡ °¡´ÉÇϸç, ÀÌ´Â ¸ð±â¿¡ ´ëÇÑ ³ëÃâµµ¿¡ µû¶ó ÇÕ¸®ÀûÀ¸·Î ¿¹¹æÁֱ⸦ °áÁ¤ÇÏ½Ã¸é µÉµí½Í½À´Ï´Ù.

1. À̹ö¸ßƾ / À̹ö¸ßƾ + ÇǶõÅÚ °è¿­ (ÇÏÆ®°¡µå, ÇÏÆ®°¡µå Ç÷¯½º, ÇÏÆ®Ä°, ¿£Á©ÇÏÆ®, ÇÏÆ®ÄÉ¾î µî)

60ÀÏ °£°Ý±îÁö 100% ±¸Á¦È¿°ú (6mcp/kg)
FDA ÀÇ NADA 138-412 ÀÇ ASR 10847 / ASR 10847 / ASR 11244 / ASR 10855 À» ÂüÁ¶Çغ¸¸é, ±ÇÀå ÇÔ·®ÀÎ 6mcp/Kg ¿¡¼­ 30ÀÏ 45ÀÏ 60Àϰ£ÀÇ ±â°£Å×½ºÆ®¿¡¼­ 100%ÀÇ ¿¹¹æÀ²À» º¸ÀΰÍÀ» È®ÀÎÇÒ¼ö ÀÖ½À´Ï´Ù. ÀÌ ½ÇÇè¿¡¼­´Â ÀÚ¿¬°¨¿°À» Å×½ºÆ®ÇѰÍÀÌ ¾Æ´Ï¶ó, ½ÇÁ¦ °¨¿°°¡´ÉÇÑ L3 À¯ÃæÀ» 30¸¶¸®¿¡¼­ 50¸¶¸®Á¤µµ ÁÖ»çÇØ Àΰø°¨¿°À» ÇÑ µÚ¿¡ ½Ç½ÃÇѰÍÀÔ´Ï´Ù. ¾àÈ¿¿¡ °üÇØ¼­´Â °ÅÀÇÁ¤È®ÇÑ ÀÚ·á°¡ ¾Æ´Ò±î ÇÕ´Ï´Ù.

2. Milbemycin Oxime °è¿­ (±¹³»: ¹Ðº£¸¶À̽ÅA-0.25mg/kg, ¹Ì±¹: Interceptor-0.5mg/kg)

30ÀÏ °£°Ý±îÁö 100% ±¸Á¦È¿°ú (0.5mg/kg)
30ÀÏ °£°Ý±îÁö 100% ±¸Á¦È¿°ú (0.1mg/Kg)
60ÀÏ / 90ÀÏ °£°Ý 95% ±¸Á¦È¿°ú (0.5mg/kg)

±Ù°ÅÀÚ·á
FDA Study No. MP-147-0285
Complete (100%) protection was achieved in dogs treated at 30 days post infection, with 95% protection at 60 and 90 days.

3. Selamectin °è¿­ (·¹º¼·ç¼Ç)
6mg/Kg ÀÇ ÇÔ·®¿¡¼­ 30/45/60ÀÏ °£°Ý 100% ±¸Á¦È¿°ú
3mg/Kg ÀÇ ÇÔ·®¿¡¼­ 30/45ÀÏ °£°Ý 100% ±¸Á¦È¿°ú

±Ù°ÅÀÚ·á

  ¿¹¹æ ¹× Ä¡·á ´ëü¿ä¹ýµé

1. Black Walnut Hul ÃßÃâ¹°
    Black Walnut Hul Àº °ËÀºÈ£µÎ³ª¹« ¿­¸ÅÀÇ ²®ÁúÀÌ ¶¥¿¡ ¶³¾îÁö±â Àü¿¡ Àç¹èÇÏ¿© ÃßÃâÇÑ ¹°Áú·Î ÁÖ ¼ººÐÀº ź´Ñ°ú Juglone À̶ó´Â ¼ººÐÀÔ´Ï´Ù. ¹Ì±¹ÀÇ Àεð¾ðµéÀº ±â»ýÃæ Á¦°Å¸¦ À§ÇØ Black Walnut À» »ç¿ëÇß¾ú´Ù°í ÇÕ´Ï´Ù. ÇöÀç Black Walnut À» ÀÌ¿ëÇÏ¿© ½ÉÀå»ç»óÃæ °¨¿°ÁõÀ» Ä¡·áÇÑ »ç·Ê°¡ ÀÎÅÍ³Ý ¹× Martin Goldstein. DVM ¹Ú»çÀÇ Ã¥¿¡¼­ ã¾Æº¼¼ö ÀÖ½À´Ï´Ù.
Martin Goldstein ¹Ú»ç´Â ÀÚ½ÅÀÇ °í°´µé¿¡°Ô Black Walnut Extract ¿Í ½ÉÀåÀ» º¸Á¶ÇØÁÖ´Â ÇãºêÀÎ Coq10 (Coenzyme Q10) À» ó¹æÇÏ¿© ¿¹¹æÀ» Çß´Ù°íÇÕ´Ï´Ù.
ÇöÀç ¿Ü±¹(¹Ì±¹ ¹× È£ÁÖ)¿¡¼­´Â Black Walnut / Wormwood / Clove µîÀÇ Çãºê¸¦ ÀÌ¿ëÇÑ ½ÉÀå»ç»óÃæ ¿¹¹æ ¹× Ä¡·á ÇÁ·Î±×·¥ÀÌ ÀÖ½À´Ï´Ù.

2. µ¿Á¾¿ä¹ý ³ë¼Òµå - CANINE HEARTWORM NOSODE 200C  
¿¹¹æÈ¿°ú°¡ ÀÖÀ¸³ª, 100% ±îÁö´Â ¾Æ´Ï¶ó´Â°ÍÀ» µ¿Á¾¿ä¹ýÀ» Àü¹®À¸·Î ÇÏ´Â ¼öÀÇ»çµéµµ ÀÎÁ¤À» ÇϴµíÇÕ´Ï´Ù. ÇÏÁö¸¸ ¾î´ÀÁ¤µµÀÇ ¿¹¹æÈ¿°ú´Â ÀÎÁ¤µÇ°íÀÖ½À´Ï´Ù. ÀÌ ³ë¼Òµå´Â ½ÉÀå»ç»óÃæ ¼ºÃæ°ú ¸¶ÀÌÅ©·Î Çʶ󸮾Ƹ¦ Èñ¼®ÇÏ¿© ¸¸µé¾îÁý´Ï´Ù. ÀÌ Nosode ¸¦ ÀÌ¿ëÇØ¼­´Â ¿¹¹æ¸¸ µÇ°í Ä¡·á´Â µÇÁö ¾Ê½À´Ï´Ù.

  ½ÉÀå»ç»óÃæ ¾à¿¡ ¹Î°¨ÇÑ °ßÁ¾


½ÉÀå»ç»óÃæ¾àÀº ±â»ýÃæÀ» Á×ÀÌ´Â ¾àÇÑ µ¶¼ºÀÌ ÀÖ´Â ¾àÀ¸·Î À̹ö¸ßƾ°è¿­ÀÇ ¾àǰµéÀº ´ëºÎºÐÀÇ ¸ñ¾ç°ßµé¿¡°Ô Å« ºÎÀÛ¿ëÀ» ÀÏÀ¸Å°´Â °ÍÀ¸·Î ¹àÇôÁ³½À´Ï´Ù. ÇöÀç±îÁö ¾Ë·ÁÁø À̹ö¸ßƾÀÇ ½ÉÀå»ç»óÃæ¾à¿¡ ºÎÀÛ¿ëÀ» Àß ÀÏÀ¸Å°´Â °ßÁ¾µéÀÔ´Ï´Ù.

Äݸ®, ¿À½ºÆ®·¼¸®¾È ¼¼Æìµå, Bearded Äݸ®, º¸´õÄݸ®, ¿Ãµå À×±Û·£µå ½±µ¶, ±×¸®°í ¼ÅƲ·£µå ½±µ¶,Whippets, Irish Water Spaniel, Bullmastiff

ÀÌ´Â À¯ÀüÀÚ gene Áß¿¡ mdr1 À̶ó´Â gene ¸¦ Æ÷ÇÔÇϰí ÀÖÀ»¶§ ¹ß»ýÇÑ´Ù´Â °ÍÀÌ À۳⿡ ¹àÇôÁ³½À´Ï´Ù. ÀÌ mdr1 À¯ÀüÀÚ¸¦ °¡Áö°í ÀÖÀ» °æ¿ì¿¡´Â ½ÉÀå»ç»óÃæ ¿¹¹æ¾à »Ó¸¸ ¾Æ´Ï¶ó ¾Æ·¡ÀÇ ¾àǰ¿¡µµ ¹Î°¨ÇÏ°Ô ¹ÝÀÀÇÏ´Â °ÍÀ¸·Î ¹àÇôÁ³½À´Ï´Ù.

Loperamide (¼³»ç Ä¡·á º¸Á¶Á¦) Doxorubicin (Ç×¾ÏÁ¦) Vincristine (Ç×¾ÏÁ¦) Vinblastine (Ç×¾ÏÁ¦) Cyclosporin (¸é¿ª ¾ïÁ¦¾à) Digoxin (½ÉÀå¾à) Acepromazine (½Å°æ¾ÈÁ¤Á¦, ÁøÁ¤Á¦) Butorphanol (ÁøÅëÁ¦)

ÀÌ mdr1 À¯ÀüÀÚ gene ÀÇ À¯¹«´Â °£´ÜÇÑ À¯ÀüÀÚ °Ë»ç¸¦ ÅëÇØ ½Äº°ÀÌ °¡´ÉÇÕ´Ï´Ù. ±¹³»¿¡µµ À¯ÀüÀÚ °Ë»ç ¼­ºñ½º¸¦ ÇØÁÖ´Â ±â°üÀÌ ÀÖÀ¸³ª, ºñ¿ëÀÌ ¸¸¸¸Ä¡ ¾ÊÀº°Ô »ç½ÇÀÔ´Ï´Ù. ¹Ì±¹ÀÇ ¿ö½ÌÅÏ ÁÖ¸³´ë¿¡¼­´Â 60ºÒ Á¤µµ¿¡ mdr1 À¯¹«¸¸ ÆÇº°ÇØÁÖ´Â ¼­ºñ½º¸¦ Çϰí ÀÖ½À´Ï´Ù. ÀÚ½ÅÀÇ °³°¡ ½ÉÀå»ç»óÃæ¾àÀ̳ª ´Ù¸¥ ¾à¹°µé¿¡ ÀÚÁÖ ºÎÀÛ¿ëÀ» ÀÏÀ¸Å²´Ù¸é ÇѹøÂë À¯ÀüÀÚ °Ë»ç¸¦ ÇØº¸´Â °Íµµ ³ª»ÚÁö ¾ÊÀ»°Í °°½À´Ï´Ù.
ÀÌ ¿Ü¿¡ ½ÉÀå»ç»óÃæ¾àÀÇ ºÎÀÛ¿ë¿¡ °¡Àå ¾ÈÀüÇÑ °ßÁ¾Àº ºñ±Û·Î ¾Ë·ÁÁ® ÀÖÀ¸¸ç, º¸Åë °³µéÀÌ Áßµ¶Áõ»óÀ» ÀÏÀ¸Å°´Â ÇÔ·®ÀÇ 100¹è¿¡¼­ 200¹è¿¡¼­±îÁöµµ ¾ÈÀüÇÏ´Ù´Â ¿¬±¸°á°ú°¡ ÀÖ½À´Ï´Ù.

  ½ÉÀå»ç»óÃæ ¿¹¹æ¾àÀÇ ºÎÀÛ¿ë

½ÉÀå»ç»óÃæ¾àÀÇ ºÎÀÛ¿ëÀº ¾Æ·¡¿Í °°½À´Ï´Ù. ½ÉÀå»ç»óÃæÀÇ ºÎÀÛ¿ëÀÌ ½É°¢ÇÑ ¼öÁØÀε¥µµ ºÒ±¸Çϰí Àß ¾Ë·ÁÁöÁö ¾ÊÀº ±î´ßÀº, ºÎÀÛ¿ëÀÌ ³ªÅ¸³ª´Â ´ëºÎºÐÀÇ ½Ã±â°¡ ¸ÔÀº 2-3½Ã°£ Á÷Èİ¡ ¾Æ´Ñ ¹Ý°¨±â - ¾àǰ¸¶´Ù Ʋ¸®Áö¸¸ 2-3ÀÏÁ¤µµ ÈÄ ¿¡ À̸£·¶À»¶§ Áï Ç÷°ü¿¡ ½ÉÀå»ç»óÃæ¾àÀÇ ¼öÄ¡°¡ ÃÖ´ëÄ¡¿¡ À̸£·¶À»¶§¿¡ Áõ»óÀÌ ³ªÅ¸³ª±â¶§¹®¿¡, ºÎÀÛ¿ëÀÌ Àß ¾Ë·ÁÁöÁö ¾ÊÀº°ÍÀÌ ¾Æ´Ñ°¡ ½Í½À´Ï´Ù.

½ÉÀå»ç»óÃæ¾àÀ» ¸ÔÀÎµÚ 2-3ÀÏÁ¤µµ±îÁö °³ÀÇ »óŸ¦ Àß »ìÆì¼­ Ȥ½Ã¶óµµ ¸ð¸¦ ºÎÀÛ¿ë¿¡ ´ëºñÇØ¾ß ÇÒ°ÍÀÔ´Ï´Ù. ±×¸®°í °¡Àå Áß¿äÇѰÍÀº ½ÉÀå»ç»óÃæ¾àÀÇ µ¶¼º¼ººÐÀ» ¸ö¹ÛÀ¸·Î ¹èÃâÇϱâ À§ÇØ °³ÀÇ °£ÀÌ ¸Å¿ì ½É°¢ÇÏ°Ô ÀÏÀ» ÇÑ´Ù´Â °ÍÀÔ´Ï´Ù. ¾Æ·¡¿¡ ³ª¿­µÈ ºÎÀÛ¿ëµéÀº short-term °ü·ÃµÈ ºÎÀÛ¿ëÀ̰í, ÇöÀç±îÁö´Â long-term Áï Àå±â°£ ½ÉÀå»ç»óÃæ¾àÀ» º¹¿ëÇßÀ»¶§ ³ªÅ¸³ª´Â ºÎÀÛ¿ë¿¡ ´ëÇØ¼­´Â Á¶»çµÈ ÀûÀÌ ¾ø½À´Ï´Ù.

¾àǰÀÇ Á¾·ùº°·Î ¾à°£¾¿ Â÷À̰¡ ÀÖÀ¸³ª ´ëºÎºÐ ¾Æ·¡¿Í °°½À´Ï´Ù. Àúµµ ¸ÔÀ̸鼭 ±â¸é, µ¿°øÈ®´ë, ±¸Åä µîÀº Á÷Á¢ °æÇèÇØº»ÀûÀÌ ÀÖ½À´Ï´Ù.

µ¿°ø È®´ë, ±â¸é, ÄÚ¸¶, ÁøÀü (¸öÀÇ ¶³¸²), º¸Çà½ÇÁ¶, È¥¼ö»óÅÂ, ±¸Åä, ħÈ긲, ±×¸®°í ±Þ»ç(°©ÀÛ½º·± Á×À½),±â¸é, È¥¼ö»óÅÂ. ½Ä¿åÀúÇÏ, ¼³»ç, °æ·Ã, Áßdz, Ÿ¸ ÈïºÐ

  ¾î¶² ¿¹¹æ¾àÀ» ¼±ÅÃÇÒ°ÍÀΰ¡?

¾î¶² ½ÉÀå»ç»óÃæ¾àÀ» ¼±ÅÃÇÒ °ÍÀΰ¡¿¡ °ü·ÃÇÏ¿© ¿©·¯°¡Áö¸¦ °í·ÁÇØºÁ¾ßÇÕ´Ï´Ù. À̹ö¸ßƾÀÇ ºÎÀÛ¿ë¿¡ ³ëÃâÀÌ ½¬¿î Äݸ®Á¾ µîÀº À̹ö¸ßƾ °è¿­ÀÌ ¾Æ´Ñ ¹Ðº£¸¶À̽ÅÀ̳ª ¼¿¶ó¸ßƾ °è¿­ÀÇ ¾àǰÀ» ¼±ÅÃÇÏ´Â °ÍÀÌ ÁÁÀ»°ÍÀ̰í, ¾àÀÇ µ¶¼º¿¡ ºñ±³Àû ´ú ¹Î°¨ÇÑ ºñ±ÛÁ¾À̶ó¸é À̹ö¸ßƾ °è¿­Áß¿¡ °¡Àå °ª½Ñ°ÍÀ» ¼±ÅÃÇÏ¸é µÉ°ÍÀÔ´Ï´Ù.

°¡Àå Áß¿äÇѰÍÀº ¸ð±â¿¡ ´ëÇÑ ³ëÃâµµ¸¦ °í·ÁÇÏ¿©, ÀÚ½ÅÀÇ °³¿¡°Ô ÀûÇÕÇÑ Á¦°¡ ÀÌ ±ÛÀ» ¾²°í³ª¼­, ¸î¸î Àå»ç¼Ó¿¡ ºü¸£½ÅºÐµéÀÌ ³»¿ëÁßÀÇ ÀϺθ¸À» ÀοëÇÏ¿© ¹¹°¡ ÁÁ´Ù ¶ó´Â½ÄÀÇ ±ÛÀ» ¾´°ÍÀ» º»ÀûÀÌ Àִµ¥ ÀÌ´Â ÈçÈ÷ ¸»ÇÏ´Â ¼º±ÞÇÑ ÀϹÝÈ­ÀÇ ¿À·ùÀÔ´Ï´Ù.

1. À̹ö¸ßƾ ¼ººÐÀÇ ¿¹¹æ¾à
À̹ö¸ßƾ ¼ººÐÀÇ ¿¹¹æ¾àÀº ½ÉÀå»ç»óÃæ¸¸ ¿¹¹æÇÒ ½Ã¿¡ È¿°úÀûÀÔ´Ï´Ù. ´Ù¸¥ ³»ºÎ±â»ýÃæÀÎ È¸Ãæ°ú ½ÊÀÌÁöÀåÃæ¿¡ È¿°ú°¡ ¾øÀ¸¹Ç·Î, µû·Î ±¸ÃæÁ¦¸¦ ¸Ô¿©¾ß ÇÏ´Â ºÒÆíÇÔÀÌ ÀÖ½À´Ï´Ù.
6ÁÖ·É ÀÌ»óÀÇ °­¾ÆÁö¿¡°Ô Åõ¾à °¡´É
ÀӽмöÀ¯°ß¿¡°Ôµµ ¾ÈÀüÇÔ


2. À̹ö¸ßƾ + ÇǶõÅÚ ÆÄ¸ð¿¹Æ® ¼ººÐÀÇ ¿¹¹æ¾à
ÀåÁ¡: ³»ºÎ±â»ýÃæ±îÁö (È¸Ãæ, ½ÊÀÌÁöÀåÃæ) ±¸ÃæÈ¿°ú°¡ ÀÖ¾î, µû·Î ³»ºÎ±â»ýÃæ¾àÀ» ¸ÔÀÌÁö ¾Ê¾ÆµµµÊ
6ÁÖ·É ÀÌ»óÀÇ °­¾ÆÁö¿¡°Ô Åõ¾à °¡´É
ÀӽмöÀ¯°ß¿¡°Ôµµ ¾ÈÀüÇÔ

3. ¹Ðº£¸¶À̽Š¿Á½É ¼ººÐÀÇ ¿¹¹æ¾à
ÀåÁ¡: È¸Ãæ, ½ÊÀÌÁöÀåÃæ ¿Ü¿¡ ÆíÃæ±îÁö ±¸Á¦°¡ µÊ. 4ÁÖ·ÉÀÌ»óÀÇ °­¾ÆÁö¿¡°Ô ±Þ¿©Çصµ ¾ÈÀüÇϸç ÀӽŰßÀ̳ª ¼öÀ¯°ß¿¡ Åõ¾àÇØµµ ¾ÈÀüÇÔ. ¾à¹°ºÎÀÛ¿ë¿¡ ¹Î°¨ÇÑ Äݸ®µîÀÇ °ßÁ¾¿¡µµ Åõ¾àÀÌ °¡´É. ¿ÀÇÁ¶óº§ Åõ¾àÀ¸·Î ¸Å¿ì ÀûÀº ÇÔ·®»ç¿ë¸¸À¸·Îµµ ½ÉÀå»ç»óÃæ ±¸Á¦°¡ °¡´É (0.1mg/Kg: FDA¿¡¼­ Å×½ºÆ®µÊ)
±¹³» À¯ÅëµÇ´Â ¹Ðº£¸¶À̽Š¿Á½É ¼ººÐÀÇ ¿¹¹æ¾àÀº FDA ¿¡¼­ ÀÎÁõµÈ ÇÔ·®(0.5mg/Kg) ÀÇ ¹ÝÀ¸·Î ÇÔ·®ÀÌ ¼³Á¤µÇ¾îÁ® ÀÖÀ½

4. ¼¿¶ó¸ßƾ ¼ººÐÀÇ ¿¹¹æ¾à
ÀåÁ¡: ¿ÜºÎ±â»ýÃæ±îÁö ±¸Á¦°¡ µÊ

5. ¸ñ½Ãµ¦Æ¾+À̴̹ÙŬ·ÎÇÁ¸®µå ¼ººÐÀÇ ¿¹¹æ¾à
¸ðµç ³»¿ÜºÎ ±â»ýÃæ¿¡ ±¸Á¦ È¿°ú°¡ ÀÖ´Ù°íÇÔ
FDA ÀÇ ÀÎÁõÀ» ¹ÞÁö ¸øÇßÀ½.
À̴̹ÙŬ·ÎÇÁ¸®µå´Â ¾àǰÀÌ ¾Æ´Ñ »ìÃæÁ¦(³ó¾àÀÇ ÁÖ¼ººÐ)·Î½á ÃßÈÄ¿¡µµ FDA ÀÇ ÀÎÁõÀ» ¹ÞÀ»¼ö ÀÖÀ»Áö Àǽɽº·¯¿ò. ¸ñ½Ãµ¦Æ¾¼ººÐÀÌ ¹Ðº£¸¶À̽Š¿Á½É¼ººÐº¸´Ù ´õ ¾ÈÀüÇÏ´Ù´Â ¿¬±¸°á°ú°¡ ÀÖÀ¸³ª, 2004³âµµ¿¡ ¸ñ½Ãµ¦Æ¾¼ººÐÀ» »ç¿ëÇÑ ÁÖ»çÁ¦ ProHeart6 °¡ FDA ÀÇ ±Ç°í¿¡ ÀÇÇØ ÀÚÁø recall ÇÏ¿´À½.        

  ½ÉÀå»ç»óÃæ¿¡ °üÇÑ À߸øµÈ ¹Ì½Åµé

1. ½ÉÀå»ç»óÃæ¾àÀ» ¸ÔÀ¸¸é 100% ½ÉÀå»ç»óÃæÀ» ¿¹¹æÇÒ¼ö ÀÖ´Ù?
    ÀÌ´Â º´¿ø ¼öÀÇ»ç ¼±»ý´ÔµéÀÌ ÁÖÀåÇÏ´Â ¹ÙÀÔ´Ï´Ù¸¸, ½ÇÁ¦·Î ½ÉÀå»ç»óÃæ¾àÀ» ¸Å´Þ ¸ÔÀ̴µ¥µµ ºÒ±¸ÇÏ°í ½ÉÀå»ç»óÃæ¿¡ °É¸®´Â °æ¿ì°¡ ²Ï ¸¹½À´Ï´Ù. ¾Æ·¡´Â FDA ¿¡ º¸°íµÈ ½ÉÀå»ç»óÃæ¾àÀÇ ºñÈ¿À²¼º¿¡ °üÇÑ Åë°èÀÔ´Ï´Ù.

Table 3. Number of dogs with reported heartworm infections that are possibly, probably, or definitely related to the ineffectiveness of marketed monthly or 6-month heartworm preventives and the number of reported deaths possibly, probably, or definitely drug-related among those dogs.  
ÆÇ¸ÅµÇ´Â ½ÉÀå»ç»óÃæ¾àÀ» ó¹æÇßÀ¸³ª, ½ÉÀå»ç»óÃæ¿¡ °¨¿°µÈ °ÍÀ¸·Î È®½ÇÈ÷ È®Àεǰųª, È®·üÀÌ ¸Å¿ì ³ô°Å³ª °¡´É¼ºÀÌ ÀÖ´Â °³µéÀÇ º¸°í ¼ýÀÚ / ±×¸®°í À̵éÁß È®½ÇÀÌ È®Àεǰųª, È®·üÀÌ ³ô°Å³ª, °¡´É¼ºÀÌ ÀÖ?°³ÀÇ Á×À½
Heartworm Preventive        Year of Initial Approval        Number of Dogs,Approval to September 1, 20042004³â ±îÁö FDA °¡ ½ÂÀÎÇÑ »ç»óÃæ¾àÀ» ¸Ô¿´Áö¸¸ »ç»óÃæ¿¡ °É·È°Å³ª È®·üÀÌ ÀÖ´Â °³µéÀÇ ¼ýÀÚ        Number of Deaths,Approval to September 1, 2004À̵éÁß ÀÌ·ÎÀÎÇØ Á×Àº °³ÀÇ ¼ýÀÚ
Ivermectin and Ivermectin/Pyrantel (all products)        1987        906        4
Milbemycin and Milbemycin/Lufenuron         1990        1610        0
Selamectin        1999        2815        11
Moxidectin Tablets(ProHeart)        1997        2        0
Moxidectin Sustained Release (ProHeart 6)        2001        411        4

2. ½ÉÀå»ç»óÃæ¿¡ °É¸®¸é ´Ù Á״´Ù?
   ¸î¸î ¹«½ÄÇÑ ¼öÀǻ缱»ý´Ôµé²²¼­ ÀÌ·¸°Ô Á¾Á¾ ¸»¾¸ÇϽðï ÇÕ´Ï´Ù¸¸..
   ½ÉÀå»ç»óÃæ °¨¿°ÁõÀº ´Ü°èº°·Î 1±â ~ 4±âÁ¤µµ±îÁö ³ª´¹´Ï´Ù. ¸»±âÀÇ °æ¿ì Ä¡·á¸¦ ÇÏ´Ù°¡ Á״°æ¿ì, ȤÀº º¹¼ö°¡ Â÷¼­ Á×´Â °æ¿ì µîÀÌ ÀÖÀ¸³ª, ½ÇÁ¦·Î ½ÉÀå»ç»óÃæ °¨¿°Áõ¸¸À¸·Î Á״°æ¿ì´Â °ÅÀÇ Èñ¹ÚÇÕ´Ï´Ù. ÇÏÁö¸¸ Áß±â ÀÌ»óÀÇ ½ÉÀå»ç»óÃæ °¨¿°À» Ä¡·áÇÏ´Ù°¡ Á×´Â °æ¿ì´Â ¸Å¿ì ¸¹½À´Ï´Ù.
À§ÀÇ Åë°èÀÚ·á¿¡¼­µµ ¾Ë¼ö ÀÖÁö¸¸, ½ÉÀå»ç»óÃæ¿¡ °¨¿°µÈ´Ù°í ÇØ¼­ Á×À½À» ¸ÂÀÌÇÏ´Â °æ¿ì´Â ±ØÈ÷ Èñ¹ÚÇÕ´Ï´Ù.


3. ½ÉÀå»ç»óÃæ¿¡ °É·ÈÀ»¶§¿¡ ½ÉÀå»ç»óÃæ¾àÀ» ¸ÔÀ¸¸é ¼îÅ©»çÇÑ´Ù? ±×·¡¼­ °Ë»çÈÄ ¸Ô¿©¾ßÇÑ´Ù.
±¹³»¿¡¼­´Â »ç¿ëµÇÁö ¾Ê¾ÒÁö¸¸, ¿¹Àü¿¡ ¹Ì±¹¿¡¼­´Â DEC ¶ó´Â ¸ÅÀϸÅÀÏ ¸ÔÀÌ´Â ½ÉÀå»ç»óÃæ¾àÀÌ ÀÖ¾ú½À´Ï´Ù. ÀÌ ¾àÀ» ¼ºÃæÀÌ Àִ»óÅ¿¡¼­ ²ÙÁØÈ÷ ¸ÔÀÌ¸é ¼îÅ©°¡ ¹ß»ýÇØ °³µéÀÌ ±Þ»çÇÏ´Â °æ¿ì°¡ ¸¹¾Ò½À´Ï´Ù. À̹ö¸ßƾÁ¦¿Í ¹Ðº£¸¶À̽Š¿Á½ÉÁ¦ ¿ª½Ã °¡º­¿î ¼îÅ©Áõ»óÀ» ÀÏÀ¸Å°³ª ±Þ»ç±îÁö´Â ÀÏÀ¸Å°Áö ¾Ê´Â°ÍÀ¸·Î ¿¬±¸µÇ¾ú½À´Ï´Ù.

½ÇÁ¦ ½ÉÀå»ç»óÃæ ÃʱⰨ¿°ÀÇ Ä¡·á¿¡´Â À̹ö¸ßƾÁ¦³ª ¹Ðº£¸¶À̽Š¿Á½ÉÁ¦¸¦ ¸Å´Þ ¸Ô¿©¼­ ¼ºÃæÀ» ¼­¼­È÷ Á×ÀÌ´Â ¹æ¹ýÀ» ÅÃÇϱ⵵ ÇÕ´Ï´Ù.

4. FDA ÀÇ ÀÎÁõÀ» ¹ÞÀº¾àÀº ¾ÈÀüÇϹǷΠ¹Ï°í ¸Ô¿©µµµÈ´Ù?
¼öÀÇ»ç ½Üµé¿¡°Ô ½ÉÀå»ç»óÃæ¾àÀÌ ¾ÈÀüÇѰ¡¿ä? ¶ó°í ¹°À¸¸é FDA ÀÇ ÀÎÁõÀ» ¹ÞÀº ¾ÈÀüÇÑ ¾àǰÀÔ´Ï´Ù. ¶ó°í ´ëºÎºÐ ¸»¾¸ÇϽʴϴÙ.
FDA (Food and Drug Administratiion) ¶ó´Â °ÍÀº ¹Ì±¹ÀÇ ½ÄÀǾàûÀÔ´Ï´Ù. ¹Ì±¹¿¡ ¾àǰÀ» À¯Åë½ÃŰ·Á¸é ´ç¿¬È÷ FDA ÀÇ ÀÎÁõÀ» ¹Þ¾Æ¾ß ÇÕ´Ï´Ù. ¹°·Ð FDA ÀÇ ÀÎÁõ±âÁØÀº ´Ù¸¥³ª¶óÀÇ ½ÄÀǾàû ÀÎÁõ±âÁØ¿¡ ºñÇØ ±²ÀåÈ÷ ±î´Ù·Î¿ì¸ç, ADE ¶ó´Â ºÎÀۿ뺸°í ¹× Åë°è Database ¸¦ ¿î¿ëÇÏ¿©, ÀÎÁõÈÄ ¾àÀÌ ½ÇÁ¦ À¯ÅëµÇ¸é¼­ »ý±â´Â ºÎÀÛ¿ëµîÀ» ÃßÈÄ ¸ð´ÏÅ͸µÇؼ­, À§ÇèÇÑ ºÎÀÛ¿ë º¸°í°¡ ¸¹À»½Ã¿¡, ÀÌ ÀÎÁõÀ» Ãë¼ÒÇϱ⵵ ÇÕ´Ï´Ù. ½ÇÁ¦·Î ½ÉÀå»ç»óÃæ ÁÖ»çÁ¦·Î ±¹³»¿¡¼­µµ À¯Åë됬¾ú´ø ProHeart6 ¶ó´Â ÁÖ»çÁ¦´Â ½É°¢ÇÑ ºÎÀۿ뺸°í·Î ÀÎÇÏ¿© 2004³â FDA ÀÇ ±Ç°í¿¡ ÀÇÇØ ÀÚÁø ½ÂÀÎ Ãë¼ÒÇÏ¿´½À´Ï´Ù.

ÃÖ¼º¿Ï 06-08-17 20:54
 
¹Ú½ÄÇϽŠÀ¯ÀÍÇÑ Á¤º¸ ³Ñ³Ñ °¨»çÇÕ´Ï´Ù
 
   
 

»çÀÌÆ®¼Ò°³   |    ±¤°í¾È³»   |    Á¦È޾ȳ»   |    °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§  |   EMAILÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ
¸¶ÀÌÇåÆÃ³Ý  °ü¸®ÀÚ: ±è½Å¸í  
Copyright (c) myhunting.net since 1999 . All Rights Reserved.